|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1991-2-12
|
|
pubmed:abstractText |
Twenty-one patients with advanced gastric adenocarcinoma were treated with a combination chemotherapy schedule of sequential methotrexate and 5-fluorouracil alternated with 4-epidoxorubicin and cisplatin. This scheme was active, with 7 partial responses leading to a response rate of 33% (+/- 20%). In two cases the tumor became operable. No severe toxicity developed and the treatment was usually well tolerated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0735-7907
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
501-4
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:2265372-Adolescent,
pubmed-meshheading:2265372-Adult,
pubmed-meshheading:2265372-Aged,
pubmed-meshheading:2265372-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2265372-Cisplatin,
pubmed-meshheading:2265372-Doxorubicin,
pubmed-meshheading:2265372-Epirubicin,
pubmed-meshheading:2265372-Female,
pubmed-meshheading:2265372-Fluorouracil,
pubmed-meshheading:2265372-Humans,
pubmed-meshheading:2265372-Male,
pubmed-meshheading:2265372-Methotrexate,
pubmed-meshheading:2265372-Middle Aged,
pubmed-meshheading:2265372-Prognosis,
pubmed-meshheading:2265372-Stomach Neoplasms
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
A phase II trial of sequential MTx and 5-FU alternated with 4-epidoxorubicin and cisplatin in advanced gastric cancer.
|
|
pubmed:affiliation |
Department of Gastroenterology, The Netherland Cancer Institute, Amsterdam.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
